Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study
- PMID: 18672302
- PMCID: PMC2721016
- DOI: 10.1016/j.ijcard.2008.05.006
Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study
Abstract
Background: Low serum magnesium levels may cause fatal ventricular arrhythmias. However, their long-term effects on mortality and morbidity in chronic heart failure patients are relatively unknown.
Methods: We studied 1569 chronic systolic and diastolic heart failure patients with normal sinus rhythm who participated in the Digitalis Investigation Group trial and had serum magnesium data available at one month. Of these, 741 patients had normal (>2 mEq/L) and 828 had low (< or =2 mEq/L) serum magnesium levels. Propensity scores for having low serum magnesium levels were calculated for each patient using a non-parsimonious multivariable logistic regression model, and were used to match 560 (76%) low-magnesium patients with 560 normal-magnesium patients. Effects of low-magnesium on mortality and hospitalization during a mean follow-up of 36 months were assessed using matched Cox regression analyses.
Results: All-cause mortality occurred in 156 (rate, 915/10,000 person-years) normal- magnesium and 171 (rate, 1034/10,000 person-years) low-magnesium patients, respectively, during 1704 and 1653 years of follow-up (hazard ratio, 1.23; 95% confidence interval, 0.97-1.57; p=0.089). Cardiovascular mortality occurred in 110 (rate, 646/10,000 person-years) normal-magnesium and 133 (rate, 805/10,000 person-years) low-magnesium patients (hazard ratio, 1.38, 95% confidence interval, 1.04-1.83, p=0.024). Hazard ratios and 95% confidence intervals for all-cause and cardiovascular hospitalizations were respectively 1.18 (0.99-1.42; p=0.068) and 1.14 (0.94-1.39; p=0.182).
Conclusions: In a propensity-matched population of ambulatory chronic heart failure patients who were balanced in all measured baseline covariates, serum magnesium level 2 mEq/L or less was associated with increased cardiovascular mortality, but had no association with cardiovascular hospitalization.
Conflict of interest statement
Figures
Similar articles
-
A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure.Eur Heart J. 2007 Jun;28(11):1334-43. doi: 10.1093/eurheartj/ehm091. Eur Heart J. 2007. PMID: 17537738 Free PMC article.
-
Race and the natural history of chronic heart failure: a propensity-matched study.J Card Fail. 2008 Jun;14(5):373-8. doi: 10.1016/j.cardfail.2008.02.004. Epub 2008 May 27. J Card Fail. 2008. PMID: 18514928 Free PMC article.
-
A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure.Int J Cardiol. 2009 Sep 11;137(1):1-8. doi: 10.1016/j.ijcard.2008.05.047. Epub 2008 Aug 8. Int J Cardiol. 2009. PMID: 18691778 Free PMC article. Clinical Trial.
-
Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study.J Card Fail. 2008 Apr;14(3):211-8. doi: 10.1016/j.cardfail.2007.12.001. J Card Fail. 2008. PMID: 18381184 Free PMC article.
-
Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial.Int J Cardiol. 2008 Jan 11;123(2):138-46. doi: 10.1016/j.ijcard.2006.12.001. Epub 2007 Mar 23. Int J Cardiol. 2008. PMID: 17382417 Free PMC article.
Cited by
-
The ECG Characteristics of Patients With Isolated Hypomagnesemia.Front Physiol. 2021 Jan 27;11:617374. doi: 10.3389/fphys.2020.617374. eCollection 2020. Front Physiol. 2021. PMID: 33584338 Free PMC article.
-
[Magnesium: Relevance for general practitioners - a position paper of the Society for Magnesium Research e. V.].Dtsch Med Wochenschr. 2020 Nov;145(22):1628-1634. doi: 10.1055/a-1166-7229. Epub 2020 Nov 3. Dtsch Med Wochenschr. 2020. PMID: 33142330 Free PMC article. German.
-
Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study.Int J Cardiol. 2012 Jan 26;154(2):128-33. doi: 10.1016/j.ijcard.2010.09.006. Epub 2010 Oct 14. Int J Cardiol. 2012. PMID: 20947188 Free PMC article.
-
Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data.Int J Cardiol. 2013 Jun 5;166(1):230-5. doi: 10.1016/j.ijcard.2011.10.089. Epub 2011 Nov 25. Int J Cardiol. 2013. PMID: 22119116 Free PMC article.
-
Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial).Am J Cardiol. 2013 Dec 1;112(11):1763-9. doi: 10.1016/j.amjcard.2013.07.020. Epub 2013 Oct 4. Am J Cardiol. 2013. PMID: 24095030 Free PMC article.
References
-
- Enselberg CD, Simmons HG, Mintz AA. The effects of magnesium upon cardiac arrhythmias. Am Heart J. 1950;39:703–12. - PubMed
-
- Burch GE, Giles TD. The importance of magnesium deficiency in cardiovascular disease. Am Heart J. 1977;94:649–57. - PubMed
-
- Gottlieb SS. Importance of magnesium in congestive heart failure. Am J Cardiol. 1989;63:39G–42G. - PubMed
-
- Sueta CA, Patterson JH, Adams KF., Jr Antiarrhythmic action of pharmacological administration of magnesium in heart failure: a critical review of new data. Magnes Res. 1995;8:389–401. - PubMed
-
- Zehender M, Meinertz T, Faber T, et al. Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. Magnesium in Cardiac Arrhythmias (MAGICA) Investigators. J Am Coll Cardiol. 1997;29:1028–34. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources